Research P pharmaphorum
Chemistry Nobel goes to molecular chirality researchers
Chemistry Nobel goes to molecular chirality researchers Phil.Taylor Thu, 08/10/2026 - 11:07
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Research P pharmaphorum
Chemistry Nobel goes to molecular chirality researchers Phil.Taylor Thu, 08/10/2026 - 11:07
Industry
MedTech Dive
Fitzgerald will oversee three newly established reportable segments as Boston Scientific works to bounce back from guidance cuts.
Clinical
Clinical Trials Arena
Aside from Vyvgart's Sjögren's fail, Argenx is eyeing further label expansion for Vyvgart Hytrulo across several immunological indications. The post Argenx cans Phase III Vyvgart Sjögren’s study on predicted efficacy fail appeared first on Clinical Trials Arena.
Software P Pistoia Alliance
AI is now a top investment for 76% of respondents, up from a 60–63% plateau since 2023 – as a lack of leadership prioritization overtakes workload as top barrier to digital transformation The post AI investment hits a four-year high as life sciences labs’ biggest barrier shifts f…
Industry
Pharmaceutical Technology
In its first global guidelines for child and adolescent obesity, the WHO says diet, exercise, and behavioural changes should be the first port of call.
Regulatory
Clinical Trials Arena
Lantern Pharma has secured regulatory and IRB clearances in Taiwan to initiate Part 2 of its Phase II HARMONIC clinical trial of LP-300 in combination with carboplatin and pemetrexed in never-smokers with advanced NSCLC. The post Lantern Pharma secures Taiwan clearances for Phase…
Regulatory
Pharmaceutical Technology
The US FDA has approved Pfizer’s Tukysa (tucatinib) along with pertuzumab and trastuzumab as a maintenance therapy for breast cancer.
Industry P pharmaphorum
PhRMA sues Trump administration over GLOBE rebate scheme Phil.Taylor Thu, 08/10/2026 - 10:01
Software A Applied Clinical Trials
In today's ACT Brief, we examine how AI surfaces design flaws before enrollment, why site training readiness depends on learning science, and the priorities defining next-generation weight-loss therapies.
Manufacturing P Pharmaceutical Executive
Pharma logistics are overqualified by design — and how agentic AI can now optimize across thousands of lanes in days, not months.
Industry P Pharmaceutical Executive
Why hub vendor transitions fail — and the four questions every manufacturer should answer before signing with a new patient support program vendor.
Industry P Pharmaceutical Executive
ESC 2026 marked a turning point — GLP-1s earn their first formal heart failure guideline recommendation and become a cardiometabolic platform.
Manufacturing
Pharmaceutical Technology
Executives from companies such as Leo Pharma and Daiichi Sankyo debated outsourcing selections and whether size is better in manufacturing.
Industry
Pharmaceutical Technology
Experts discuss the latest research released at EASD 2026 and what it could mean for the diabetes community.
Clinical
European Biotechnology
Argenx is stopping its Phase 3 UNITY trial of efgartigimod in Sjögren’s disease after an interim analysis showed the study could not meet its primary endpoint. Shares fell about 18% in Euronext Brussels trading following the announcement, overshadowing positive Phase 2 results fo…
Clinical
Clinical Trials Arena
As clinical trials become more complex, the onus is on sites and investigators to fulfil the demands of a highly customised trial. The post Podcast: Customising clinical trials without increasing patient burden appeared first on Clinical Trials Arena.
Funding P pharmaphorum
UAE investment drives Middle East biopharma transformation as precision medicine set for double-digit growth Sara.Scarpinati Thu, 08/10/2026 - 08:37
Industry
STAT Biotech
Smaller biotech firms are trying to figure out how to win exemptions from Trump's import taxes.
Industry
STAT Biotech
“Don’t google,” the pediatric geneticist warned. It took me five years to disobey.
Funding P pharmaphorum
Biohub raises $1.8bn for its 'virtual biology' initiative Phil.Taylor Thu, 08/10/2026 - 08:03
Regulatory
Clinical Trials Arena
Dignify Therapeutics has secured IND clearance from the US FDA to advance DTI-117 into a Phase I trial for neurogenic bowel dysfunction (NBD). The post Dignify Therapeutics secures FDA clearance for Phase I DTI-117 trial appeared first on Clinical Trials Arena.
Research
Pharmaceutical Technology
10x Genomics has entered into a multi-project research agreement with Fred Hutch for advancing single cell as well as spatial platforms in solid tumours and blood cancers.
Agriculture E European Seed
Research from the Boyce Thompson Institute shows how wild tomato relatives may help breeders recover flavour and nutritional traits without sacrificing yield, fruit size or shelf life. The study maps regulatory switches tied to tomato fruit quality. The post The Flavour Tomato Br…
Industry
BioSpace
Biotechs developing therapeutics to treat rare diseases include two that received FDA approvals this year for drugs to treat spinal muscular atrophy and Alexander disease.
Clinical
Inside Precision Medicine
Age-based testing criteria could miss 72% of cancer patients carrying inherited pathogenic variants, potentially overlooking information important for treatment, prevention, and families. The post Age-Based Genetic Testing Misses 72% of Patients with Inherited Cancer Variants app…
Funding
BioSpace
Big Pharma companies including Bristol Myers Squibb, Johnson & Johnson and Novartis are among those that made or planned layoffs in Q3. Those cuts could affect over 1,800 employees, with New Jersey the hardest-hit state.
Industry S Science News
Samples from Japan’s MMX mission could reveal how Phobos formed—and may contain pieces of Mars
Industry S Science News
Using genome editing to trace cell lineages, researchers capture the early history of the mouse embryo in unprecedented detail
Industry S Science News
Researchers concluded that doomsday will fall on 13 November—but not for the reasons we might expect today
Industry
BioCentury
BIOCENTURY | FINANCE3Q26 WRAP: FLAT AS A PANCAKEWinners, losers in biotech stock tiers in 3Q26
Industry
BioCentury
BIOCENTURY | PRODUCT DEVELOPMENTINVASIVE FUNGAL INFECTIONS: A PIPELINE FINALLY BRANCHING BEYOND THE CELL WALLMapping the mechanisms of nine clinical-stage antifungal programs to pathogen coverage
Funding
BioCentury
BIOCENTURY | MANAGEMENT TRACKSLAYOFFS AT CARIBOU AS TWO CAR TS SCRAPPEDPlus: David Liu joining Vir as CMO — and more
Industry N Nature Medicine
Industry N Nature Reviews Bioengineering
Manufacturing B BioProcess International
The company’s aptly named Dalton engine claims it can discover and manage antibodies at scale.
Industry
BioCentury
BIOCENTURY | DISCOVERY & TRANSLATIONINNOVATION RADAR: OSTEOARTHRITIS SIGNALS THAT DON’T START IN THE JOINTNew studies point to hormones, fat-derived vesicles, and fatty acids that speed cartilage loss in joints already weakened by injury or age
Industry
Inside Precision Medicine
HPV vaccination offers benefits beyond lowering the risk of cervical cancer and also prevents adverse pregnancy outcomes in women such as preterm birth. The post HPV Vaccination Prevents Major Pregnancy Complications appeared first on Inside Precision Medicine.
Agriculture E European Seed
Genomic prediction pricing has turned into a rumor market. The figures you hear at breeding conferences, and will hear in Valencia at Euroseeds, span two orders of magnitude — and […] The post What Genomic Prediction is Worth to Your Program appeared first on Seed World.
Industry
Inside Precision Medicine
A small clinical study found that an optogenetic treatment paired with specialized goggles safely improved light sensitivity in some people with advanced retinitis pigmentosa, regardless of the underlying genetic cause. The post Optogenetic Therapy Shows Early Promise for Retinit…
Industry
Fierce Pharma
Why MRC Accreditation Is Just the First Step pesurya Wed, 10/07/2026 - 15:58